Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study
Abstract Background The Toronto hepatocellular carcinoma (HCC) risk index (THRI) was developed to predict HCC in patients with cirrhosis. This study aimed to validate the THRI in a 10-year Asian cohort. Methods A total of 2836 patients with cirrhosis at the First Affiliated Hospital of Soochow Unive...
Main Authors: | Huixian Zhang, Jinzhou Zhu, Liting Xi, Chunfang Xu, Airong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-019-1619-3 |
Similar Items
-
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
by: Hanne Åström, et al.
Published: (2021-10-01) -
Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01) -
A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
by: Dong W, et al.
Published: (2020-07-01) -
Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
by: Moiz Ahmed, et al.
Published: (2021-03-01) -
Role of bile acids in the prediction of hepatocellular carcinoma in HCV-induced liver cirrhosis
by: Ashraf Khalil, et al.
Published: (2021-09-01)